Medicine Creek Counseling - Medicare Mental Health Clinic in Cambridge, NE

Medicine Creek Counseling is a medicare enrolled mental health clinic (Community/behavioral Health) in Cambridge, Nebraska. The current practice location for Medicine Creek Counseling is 301 Nelson Street, Cambridge, Nebraska. For appointments, you can reach them via phone at (308) 737-3051. The mailing address for Medicine Creek Counseling is Po Box 297, Cambridge, Nebraska and phone number is (308) 641-6387.

Medicine Creek Counseling is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1114537529. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (308) 737-3051.

Contact Information

Medicine Creek Counseling
301 Nelson Street
Cambridge
NE 69022-3592
(308) 737-3051
Not Available

Mental Health Clinic Profile

Full NameMedicine Creek Counseling
SpecialityCommunity/Behavioral Health
Location301 Nelson Street, Cambridge, Nebraska
Authorized Official Name and PositionWendy Elizabeth Shifflet (LICENSED MENTAL HEALTH THERAPIST)
Authorized Official Contact3087373051
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Medicine Creek Counseling
Po Box 297
Cambridge
NE 69022-0297

Ph: (308) 641-6387
Medicine Creek Counseling
301 Nelson Street
Cambridge
NE 69022-3592

Ph: (308) 737-3051

NPI Details:

NPI Number1114537529
Provider Enumeration Date08/01/2020
Last Update Date02/21/2024
Certification Date02/19/2024

Medicare PECOS Information:

Medicare PECOS PAC ID4082039789
Medicare Enrollment IDO20200728003393

News Archive

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

Racial differences in parents' reports of child's autism symptoms may contribute to delayed diagnosis

Racial differences in parents' reports of concerns about their child's development to healthcare providers may contribute to delayed diagnosis of autism spectrum disorder (ASD) in black children, according to a study led by Georgia State University.

Rare disease diagnosis by 100,000 genomes pilot

A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.

State-of-the-art portable biosensing device based on micro and nanotechnologies

A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.

Niacin findings could open up new avenues for drug discovery

Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Medicine Creek Counseling such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1114537529NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
251S00000XCommunity/behavioral Health (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicine Creek Counseling acts as a billing entity for following providers:
Provider NameWendy E Shifflet
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1952878233
PECOS PAC ID: 6406277797
Enrollment ID: I20200521001668

News Archive

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

Racial differences in parents' reports of child's autism symptoms may contribute to delayed diagnosis

Racial differences in parents' reports of concerns about their child's development to healthcare providers may contribute to delayed diagnosis of autism spectrum disorder (ASD) in black children, according to a study led by Georgia State University.

Rare disease diagnosis by 100,000 genomes pilot

A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.

State-of-the-art portable biosensing device based on micro and nanotechnologies

A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.

Niacin findings could open up new avenues for drug discovery

Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.

Read more Medical News

› Verified 2 days ago

Provider NameSarah Sweeterman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1265055636
PECOS PAC ID: 6901261411
Enrollment ID: I20230504002210

News Archive

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

Racial differences in parents' reports of child's autism symptoms may contribute to delayed diagnosis

Racial differences in parents' reports of concerns about their child's development to healthcare providers may contribute to delayed diagnosis of autism spectrum disorder (ASD) in black children, according to a study led by Georgia State University.

Rare disease diagnosis by 100,000 genomes pilot

A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.

State-of-the-art portable biosensing device based on micro and nanotechnologies

A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.

Niacin findings could open up new avenues for drug discovery

Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.

Read more Medical News

› Verified 2 days ago

News Archive

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

Racial differences in parents' reports of child's autism symptoms may contribute to delayed diagnosis

Racial differences in parents' reports of concerns about their child's development to healthcare providers may contribute to delayed diagnosis of autism spectrum disorder (ASD) in black children, according to a study led by Georgia State University.

Rare disease diagnosis by 100,000 genomes pilot

A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.

State-of-the-art portable biosensing device based on micro and nanotechnologies

A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.

Niacin findings could open up new avenues for drug discovery

Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.

Read more News

› Verified 2 days ago

Community/Behavioral Health in Cambridge, NE


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.